Skip to main content
Livermore
Livermore
ZHEN

NewEdge Wealth, LLC

SEC CIK
0001861796
Latest filing
Aug 10, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by NewEdge Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
967
Value
$602.8K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of REGN by NewEdge Wealth, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026967$602.8K<0.1%+382+65.3%AddedHolders
Q1 2026585$452.3K<0.1%−781−57.2%ReducedHolders
Q4 20251,366$1.05M<0.1%+845+162.2%AddedHolders
Q3 2025521$335.6K<0.1%+521NewHolders
Q2 20250$00.0%−669−100.0%Sold outHolders
Q1 2025669$424.5K<0.1%−40,096−98.4%ReducedHolders
Q4 202440,765$29.0M0.5%+3,636+9.8%AddedHolders
Q3 202437,129$39.0M0.7%+858+2.4%AddedHolders
Q2 202436,271$38.1M0.8%+110.0%AddedHolders
Q1 202436,260$34.0M0.8%+3,541+10.8%AddedHolders
Q4 202332,719$28.7M0.7%+4,287+15.1%AddedHolders
Q3 202328,432$23.4M0.7%+7,099+33.3%AddedHolders
Q2 202321,333$15.3M0.5%+737+3.6%AddedHolders
Q1 202320,596$16.9M0.6%+983+5.0%AddedHolders
Q4 202219,613$14.2M0.6%+875+4.7%AddedHolders
Q3 202218,738$12.9M0.6%+1,864+11.0%AddedHolders
Q2 202216,874$9.97M0.5%+571+3.5%AddedHolders
Q1 202216,303$11.4M0.5%+6,989+75.0%AddedHolders
Q4 20219,314$5.88M0.2%+9,314NewHolders
Q2 20210$00.0%−1,188−100.0%Sold outHolders
Q1 20211,188$562.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.